- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02689648
Long Term Follow up on Functional Gastrointestinal Disorder (FGID) (LUFT)
May 23, 2022 updated by: Staffan Berglund, Umeå University
Long term prognosis and risk factors in functional gastrointestinal disorder (FGID) is largely unknown.
The investigators plan to retrospectively analyse a cohort of children who were referred to the Pediatric Clinic due to abdominal pain with the aims to learn more about symptoms and effects of investigations performed.
Furthermore, the investigators plan to contact the cases for a follow up using a validated questionnaire and analyse the long term prognosis and risk factors for prolonged severe symptoms.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Long term prognosis and risk factors in functional gastrointestinal disorder (FGID) is largely unknown.
The investigators plan to retrospectively analyse a cohort of children who during the years 2010-2015 were referred to the Pediatric Clinic of Umeå University Hospital due to abdominal pain.
The aims are to explore and descriptively describe the symptoms and effects of investigations performed.
Furthermore, the investigators plan to contact the cases five years after the first contact for a follow up using a validated questionnaire of the ROME-III-criteria and analyse the long term prognosis and risk factors for prolonged severe symptoms.
Study Type
Observational
Enrollment (Anticipated)
400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Staffan K Berglund
- Phone Number: +46703956767
- Email: staffan.berglund@umu.se
Study Locations
-
-
-
Umeå, Sweden, 90185
- Recruiting
- Umeå University, Department of Clinical Sciences
-
Contact:
- Staffan K Berglund, MD, PhD
- Phone Number: +46703956767
- Email: staffan.berglund@umu.se
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All children between 3 and 18 years of age that were refereed to the Pediatric Clinic of Västerbotten county council during the years 2009-2015.
Description
At time of first visit the children had:
- At least 2 months of abdominal pain
- Age 3-18 years
- No organic gastrointestinal diseases
- No neuromuscular disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage (%) of patients that fulfill the ROME-III criteria for FGID
Time Frame: 5 years after fist visit +/- 1 year
|
Measured by the validated ROME-III questionnaire
|
5 years after fist visit +/- 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
ICD 10-diagnosis following the primary investigation
Time Frame: 12 months after first visit
|
12 months after first visit
|
Current ICD 10-diagnosis
Time Frame: 5 years after fist visit +/- 1 year
|
5 years after fist visit +/- 1 year
|
Number (n) of visits for the primary investigations
Time Frame: 0-12 months after first visit
|
0-12 months after first visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Staffan K Berglund, Umea University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2016
Primary Completion (Anticipated)
January 1, 2024
Study Completion (Anticipated)
January 1, 2025
Study Registration Dates
First Submitted
February 8, 2016
First Submitted That Met QC Criteria
February 23, 2016
First Posted (Estimate)
February 24, 2016
Study Record Updates
Last Update Posted (Actual)
May 24, 2022
Last Update Submitted That Met QC Criteria
May 23, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LUFT2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Functional Gastrointestinal Disorder
-
The University of Texas Medical Branch, GalvestonCompletedGastrointestinal Disorders, Functional
-
Chang Gung Memorial HospitalNew Bellus EnterprisesUnknownNeoplasm | Functional Gastrointestinal DisorderTaiwan
-
TriHealth Inc.CompletedGastrointestinal Disorder, FunctionalUnited States
-
Chinese University of Hong KongCompletedFunctional Gastrointestinal DisorderHong Kong
-
DSM Nutritional Products, Inc.WithdrawnGastrointestinal Disorder, Functional
-
Washington University School of MedicineNovartis PharmaceuticalsTerminatedKidney Transplant Rejection | Gastrointestinal Disorder, FunctionalUnited States
-
Medical University of BialystokManiac Gym Bialystok; University Teaching Hospital, BialystokCompletedGastrointestinal Disorder, FunctionalPoland
-
University of Veterinary and Animal Sciences, Lahore...CompletedSmall Intestinal Bacterial Overgrowth | Gastrointestinal Disorder, FunctionalPakistan
-
Colorado State UniversityMetabiomics Corp; George Mason UniversityCompletedGastrointestinal Disorder, Functional
-
University of RochesterCompletedFunctional Disorder of IntestineUnited States